This, together with the fact that the increase in astrocytic FABP7 expression is observed not only in the APP/PS1 mouse model but also in the brain of AD patients, supports the relevance and potential contribution of this observation to the neuroinflammatory environment observed in AD pathology. Here, FABP7 is linked to Alzheimer disease.